{"slug":"lung-deep-dive","tag":"lung-deep-dive","variants":["lung-deep-dive"],"description":"Registry-only phase 2 and 3 trials that name lung, non-small-cell lung or small-cell lung cancer in their title or conditions, recorded from ClinicalTrials.gov during the lung cancer deep dive of September 2026; registry facts only, no outcomes.","count":323,"kinds":{"trial":323},"related":[],"records":[{"id":"nct04695925","kind":"trial","name":"Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations","route":"/trials/nct04695925/","status":"active","tldr":"A phase 3 trial of osimertinib, pemetrexed and carboplatin in lung cancer, run by Li Zhang, MD, active but no longer recruiting."},{"id":"nct06031558","kind":"trial","name":"Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC","route":"/trials/nct06031558/","status":"active","tldr":"A phase 3 trial in lung cancer, run by Shouyao Holdings (Beijing) Co. LTD, active but no longer recruiting."},{"id":"nct05943795","kind":"trial","name":"A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma","route":"/trials/nct05943795/","status":"active","tldr":"A phase 3 trial of SI-B001 and docetaxel in lung cancer, run by Sichuan Baili Pharmaceutical Co., Ltd., active but no longer recruiting."},{"id":"nct03811002","kind":"trial","name":"Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lun","route":"/trials/nct03811002/","status":"active","tldr":"A phase 3 trial of atezolizumab, carboplatin, cisplatin and etoposide in lung cancer, run by National Cancer Institute (NCI), active but no longer recruiting."},{"id":"nct06872541","kind":"trial","name":"Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas","route":"/trials/nct06872541/","status":"active","tldr":"A phase 2/3 trial in lung cancer, run by University of Sao Paulo, active but no longer recruiting."},{"id":"nct01993810","kind":"trial","name":"Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer","route":"/trials/nct01993810/","status":"active","tldr":"A phase 3 trial of carboplatin, cisplatin, durvalumab, etoposide and other drugs in lung cancer, run by Radiation Therapy Oncology Group, active but no longer recruiting."},{"id":"nct03391869","kind":"trial","name":"Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer","route":"/trials/nct03391869/","status":"active","tldr":"A phase 3 trial of ipilimumab and nivolumab in lung cancer, run by M.D. Anderson Cancer Center, active but no longer recruiting."},{"id":"nct03774732","kind":"trial","name":"PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer","route":"/trials/nct03774732/","status":"active","tldr":"A phase 3 trial of pembrolizumab in lung cancer, run by UNICANCER, active but no longer recruiting."},{"id":"nct04597671","kind":"trial","name":"Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)","route":"/trials/nct04597671/","status":"active","tldr":"A phase 3 trial of durvalumab in lung cancer, run by Association NVALT Studies, active but no longer recruiting."},{"id":"nct07076693","kind":"trial","name":"Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）","route":"/trials/nct07076693/","status":"active","tldr":"A phase 2/3 trial in lung cancer, run by Shanghai Chest Hospital, active but no longer recruiting."},{"id":"nct04804644","kind":"trial","name":"Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of M","route":"/trials/nct04804644/","status":"active","tldr":"A phase 3 trial in lung cancer, run by NRG Oncology, active but no longer recruiting."},{"id":"nct04536675","kind":"trial","name":"Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery","route":"/trials/nct04536675/","status":"active","tldr":"A phase 3 trial in lung cancer, run by Samsung Medical Center, active but no longer recruiting."},{"id":"nct04929041","kind":"trial","name":"Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Pati","route":"/trials/nct04929041/","status":"active","tldr":"A phase 2/3 trial of ipilimumab and nivolumab in lung cancer, run by National Cancer Institute (NCI), active but no longer recruiting."},{"id":"nct06632327","kind":"trial","name":"Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer","route":"/trials/nct06632327/","status":"active","tldr":"A phase 3 trial of cisplatin, carboplatin, pemetrexed, gemcitabine and other drugs in lung cancer, run by Alliance for Clinical Trials in Oncology, active but no longer recruiting."},{"id":"nct04214262","kind":"trial","name":"Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer","route":"/trials/nct04214262/","status":"active","tldr":"A phase 3 trial of atezolizumab and fludeoxyglucose F-18 (FDG) in lung cancer, run by National Cancer Institute (NCI), active but no longer recruiting."},{"id":"nct05096663","kind":"trial","name":"Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer","route":"/trials/nct05096663/","status":"active","tldr":"A phase 2/3 trial of dexamethasone, docetaxel, gemcitabine, pembrolizumab and other drugs in lung cancer, run by SWOG Cancer Research Network, active but no longer recruiting."},{"id":"nct04547504","kind":"trial","name":"PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %","route":"/trials/nct04547504/","status":"active","tldr":"A phase 3 trial of pembrolizumab in lung cancer, run by University Hospital, Brest, active but no longer recruiting."},{"id":"nct04155034","kind":"trial","name":"S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cel","route":"/trials/nct04155034/","status":"active","tldr":"A phase 3 trial in lung cancer, run by SWOG Cancer Research Network, active but no longer recruiting."},{"id":"nct03637816","kind":"trial","name":"Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer","route":"/trials/nct03637816/","status":"active","tldr":"A phase 2/3 trial in lung cancer, run by M.D. Anderson Cancer Center, active but no longer recruiting."},{"id":"nct04093167","kind":"trial","name":"Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer","route":"/trials/nct04093167/","status":"active","tldr":"A phase 2/3 trial of pembrolizumab in lung cancer, run by Canadian Cancer Trials Group, active but no longer recruiting."},{"id":"nct04564157","kind":"trial","name":"New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy","route":"/trials/nct04564157/","status":"active","tldr":"A phase 3 trial of carboplatin, paclitaxel / nab-paclitaxel and nivolumab in lung cancer, run by Fundación GECP, active but no longer recruiting."},{"id":"nct06505837","kind":"trial","name":"JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）","route":"/trials/nct06505837/","status":"active","tldr":"A phase 3 trial of pemetrexed and toripalimab in lung cancer, run by Shanghai Junshi Bioscience Co., Ltd., active but no longer recruiting."},{"id":"nct03977194","kind":"trial","name":"Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy","route":"/trials/nct03977194/","status":"active","tldr":"A phase 3 trial of carboplatin, paclitaxel / nab-paclitaxel and atezolizumab in lung cancer, run by Intergroupe Francophone de Cancerologie Thoracique, active but no longer recruiting."},{"id":"nct03793179","kind":"trial","name":"Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer","route":"/trials/nct03793179/","status":"active","tldr":"A phase 3 trial of carboplatin, pembrolizumab and pemetrexed in lung cancer, run by National Cancer Institute (NCI), active but no longer recruiting."},{"id":"nct04841811","kind":"trial","name":"MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)","route":"/trials/nct04841811/","status":"active","tldr":"A phase 3 trial of aumolertinib in lung cancer, run by Guangdong Association of Clinical Trials, active but no longer recruiting."},{"id":"nct04092283","kind":"trial","name":"Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Anti","route":"/trials/nct04092283/","status":"active","tldr":"A phase 3 trial of carboplatin, cisplatin, durvalumab, etoposide and other drugs in lung cancer, run by National Cancer Institute (NCI), active but no longer recruiting."},{"id":"nct06732401","kind":"trial","name":"Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer","route":"/trials/nct06732401/","status":"active","tldr":"A phase 3 trial of ceralasertib and durvalumab in lung cancer, run by National Cancer Institute (NCI), active but no longer recruiting."},{"id":"nct06500455","kind":"trial","name":"Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain","route":"/trials/nct06500455/","status":"active","tldr":"A phase 3 trial in lung cancer, run by NRG Oncology, active but no longer recruiting."},{"id":"nct06281964","kind":"trial","name":"Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.","route":"/trials/nct06281964/","status":"recruiting","tldr":"A phase 3 trial of pemetrexed in lung cancer, run by Avistone Biotechnology Co., Ltd., now recruiting."},{"id":"nct06370416","kind":"trial","name":"the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib","route":"/trials/nct06370416/","status":"recruiting","tldr":"A phase 2 trial of trilaciclib in lung cancer, run by Henan Cancer Hospital, now recruiting."},{"id":"nct06759857","kind":"trial","name":"FHND9041 Versus Afatinib for Non-small Cell Lung Cancer","route":"/trials/nct06759857/","status":"recruiting","tldr":"A phase 3 trial of afatinib in lung cancer, run by Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., now recruiting."},{"id":"nct04762459","kind":"trial","name":"Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Com","route":"/trials/nct04762459/","status":"recruiting","tldr":"A phase 3 trial of aumolertinib, pemetrexed and cisplatin in lung cancer, run by Chinese Academy of Medical Sciences, now recruiting."},{"id":"nct06419179","kind":"trial","name":"Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extens","route":"/trials/nct06419179/","status":"recruiting","tldr":"A phase 2 trial of durvalumab and olaparib in lung cancer, run by University of Cologne, now recruiting."},{"id":"nct07710612","kind":"trial","name":"A Phase 2 Study of ABSK043 Combined With Osimertinib","route":"/trials/nct07710612/","status":"planned","tldr":"A phase 2 trial of osimertinib in lung cancer, run by Abbisko Therapeutics Co, Ltd, not yet recruiting."},{"id":"nct07355231","kind":"trial","name":"Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI","route":"/trials/nct07355231/","status":"planned","tldr":"A phase 1/2 trial in lung cancer, run by Xemed LLC, not yet recruiting."},{"id":"nct07796100","kind":"trial","name":"A Study of ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Ther","route":"/trials/nct07796100/","status":"planned","tldr":"A phase 3 trial of carboplatin and lurbinectedin in lung cancer, run by Zai Lab (Shanghai) Co., Ltd., not yet recruiting."},{"id":"nct07477808","kind":"trial","name":"Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer","route":"/trials/nct07477808/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Hunan Province Tumor Hospital, not yet recruiting."},{"id":"nct07234877","kind":"trial","name":"Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets","route":"/trials/nct07234877/","status":"planned","tldr":"A phase 2 trial of ivonescimab, carboplatin, pemetrexed, paclitaxel / nab-paclitaxel and other drugs in lung cancer, run by European Organisation for Research and Treatment of Cancer - EORTC, not yet recruiting."},{"id":"nct07169903","kind":"trial","name":"Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT","route":"/trials/nct07169903/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Shanghai Pulmonary Hospital, Shanghai, China, not yet recruiting."},{"id":"nct05496166","kind":"trial","name":"The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Canc","route":"/trials/nct05496166/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Shanghai Pulmonary Hospital, Shanghai, China, not yet recruiting."},{"id":"nct05186506","kind":"trial","name":"A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer","route":"/trials/nct05186506/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Sichuan University, not yet recruiting."},{"id":"nct07637513","kind":"trial","name":"Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer","route":"/trials/nct07637513/","status":"planned","tldr":"A phase 3 trial of tarlatamab and durvalumab in lung cancer, run by PrECOG, LLC., not yet recruiting."},{"id":"nct07285148","kind":"trial","name":"A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer","route":"/trials/nct07285148/","status":"planned","tldr":"A phase 1/2 trial of osimertinib in lung cancer, run by Beijing Pearl Biotechnology Limited Liability Company, not yet recruiting."},{"id":"nct07742956","kind":"trial","name":"Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK201 for Injection in Combination With Ivonescimab In","route":"/trials/nct07742956/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Shanghai Allink Biotherapeutics Co., Ltd., not yet recruiting."},{"id":"nct07063329","kind":"trial","name":"Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive","route":"/trials/nct07063329/","status":"planned","tldr":"A phase 1/2 trial in lung cancer, run by Avistone Pharmaceutical（Ningbo）Co., LTD., not yet recruiting."},{"id":"nct06970782","kind":"trial","name":"Vebreltinib Plus PLB1004 Versus Platinum-based Doublet Chemotherapy in Patients With EGFRm, MET+, Locally Advanced or Metastatic NSCLC Following EGFR-TKI Failur","route":"/trials/nct06970782/","status":"planned","tldr":"A phase 3 trial of vebreltinib and pemetrexed in lung cancer, run by Avistone Biotechnology Co., Ltd., not yet recruiting."},{"id":"nct07360132","kind":"trial","name":"Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous","route":"/trials/nct07360132/","status":"planned","tldr":"A phase 3 trial of carboplatin and paclitaxel / nab-paclitaxel in lung cancer, run by Shanghai Huaota Biopharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07289646","kind":"trial","name":"Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy","route":"/trials/nct07289646/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by University Hospital, Brest, not yet recruiting."},{"id":"nct05859217","kind":"trial","name":"A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)","route":"/trials/nct05859217/","status":"planned","tldr":"A phase 2 trial of cabozantinib and atezolizumab in lung cancer, run by Jun Zhang, MD, PhD, not yet recruiting."},{"id":"nct07739199","kind":"trial","name":"A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line","route":"/trials/nct07739199/","status":"planned","tldr":"A phase 2/3 trial of izalontamab brengitecan, paclitaxel / nab-paclitaxel and carboplatin in lung cancer, run by Sichuan Baili Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07808138","kind":"trial","name":"RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer","route":"/trials/nct07808138/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by The Netherlands Cancer Institute, not yet recruiting."},{"id":"nct07501169","kind":"trial","name":"Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)","route":"/trials/nct07501169/","status":"planned","tldr":"A phase 2 trial of sacituzumab tirumotecan and anlotinib in lung cancer, run by Sichuan University, not yet recruiting."},{"id":"nct05764928","kind":"trial","name":"Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy","route":"/trials/nct05764928/","status":"planned","tldr":"A phase 1/2 trial in lung cancer, run by Rgene Corporation, not yet recruiting."},{"id":"nct07704645","kind":"trial","name":"The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer","route":"/trials/nct07704645/","status":"planned","tldr":"A phase 2 trial of adebrelimab in lung cancer, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., not yet recruiting."},{"id":"nct05767892","kind":"trial","name":"YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations","route":"/trials/nct05767892/","status":"planned","tldr":"A phase 3 trial of pemetrexed, carboplatin and cisplatin in lung cancer, run by Suzhou Puhe Pharmaceutical Technology Co., LTD, not yet recruiting."},{"id":"nct04153734","kind":"trial","name":"Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC","route":"/trials/nct04153734/","status":"planned","tldr":"A phase 2 trial of pembrolizumab, carboplatin, pemetrexed and nab-paclitaxel in lung cancer, run by Kobe Minimally Invasive Cancer Center, not yet recruiting."},{"id":"nct06526624","kind":"trial","name":"A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer","route":"/trials/nct06526624/","status":"planned","tldr":"A phase 3 trial of HS-20093 in lung cancer, run by Hansoh BioMedical R&D Company, not yet recruiting."},{"id":"nct06908772","kind":"trial","name":"Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients","route":"/trials/nct06908772/","status":"planned","tldr":"A phase 2/3 trial in lung cancer, run by Shanghai JMT-Bio Inc., not yet recruiting."},{"id":"nct07718737","kind":"trial","name":"Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Can","route":"/trials/nct07718737/","status":"planned","tldr":"A phase 2/3 trial of AMT-116 and ramucirumab in lung cancer, run by Multitude Therapeutics Inc., not yet recruiting."},{"id":"nct06456138","kind":"trial","name":"Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC","route":"/trials/nct06456138/","status":"planned","tldr":"A phase 1/2 trial of trametinib, anlotinib and tislelizumab in lung cancer, run by Shanghai Chest Hospital, not yet recruiting."},{"id":"nct06847334","kind":"trial","name":"A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous","route":"/trials/nct06847334/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Shanghai Henlius Biotech, not yet recruiting."},{"id":"nct07798947","kind":"trial","name":"A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC","route":"/trials/nct07798947/","status":"planned","tldr":"A phase 2 trial of adebrelimab in lung cancer, run by Shanghai Hengrui Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06045767","kind":"trial","name":"T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer","route":"/trials/nct06045767/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Ari Raphael, not yet recruiting."},{"id":"nct07560358","kind":"trial","name":"Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer","route":"/trials/nct07560358/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting."},{"id":"nct07076095","kind":"trial","name":"A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer","route":"/trials/nct07076095/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by SUNHO（China）BioPharmaceutical CO., Ltd., not yet recruiting."},{"id":"nct07256509","kind":"trial","name":"A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous No","route":"/trials/nct07256509/","status":"planned","tldr":"A phase 2 trial of SYS6010, osimertinib, pemetrexed, cisplatin and other drugs in lung cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., not yet recruiting."},{"id":"nct06955325","kind":"trial","name":"Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations","route":"/trials/nct06955325/","status":"planned","tldr":"A phase 3 trial of icotinib, ensartinib and benmelstobart in lung cancer, run by The First Affiliated Hospital of Guangzhou Medical University, not yet recruiting."},{"id":"nct07416058","kind":"trial","name":"PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC","route":"/trials/nct07416058/","status":"planned","tldr":"A phase 2 trial of iparomlimab and tuvonralimab in lung cancer, run by Guangdong Association of Clinical Trials, not yet recruiting."},{"id":"nct07135882","kind":"trial","name":"Primary Radiotherapy In MEtastatic Lung Cancer","route":"/trials/nct07135882/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Trans Tasman Radiation Oncology Group, not yet recruiting."},{"id":"nct07402070","kind":"trial","name":"IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer","route":"/trials/nct07402070/","status":"planned","tldr":"A phase 2 trial of IBI363 in lung cancer, run by Innovent Biologics (Suzhou) Co. Ltd., not yet recruiting."},{"id":"nct07545213","kind":"trial","name":"Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis","route":"/trials/nct07545213/","status":"planned","tldr":"A phase 2 trial of sacituzumab tirumotecan in lung cancer, run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine, not yet recruiting."},{"id":"nct07723482","kind":"trial","name":"ML-016 in Advanced Cancer With Lung and/or Liver Involvement","route":"/trials/nct07723482/","status":"planned","tldr":"A phase 1/2 trial in lung cancer, run by BrYet US, Inc., not yet recruiting."},{"id":"nct07318883","kind":"trial","name":"A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab","route":"/trials/nct07318883/","status":"planned","tldr":"A phase 2/3 trial of serplulimab, pembrolizumab and carboplatin in lung cancer, run by Shanghai Henlius Biotech, not yet recruiting."},{"id":"nct07739966","kind":"trial","name":"A Study of DS-3939a in Participants With Solid Tumors","route":"/trials/nct07739966/","status":"planned","tldr":"A phase 1/2 trial of pembrolizumab, carboplatin and pemetrexed in lung cancer, run by Daiichi Sankyo, not yet recruiting."},{"id":"nct06581380","kind":"trial","name":"JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer","route":"/trials/nct06581380/","status":"planned","tldr":"A phase 3 trial of topotecan in lung cancer, run by JenKem Technology Co., Ltd., not yet recruiting."},{"id":"nct07728955","kind":"trial","name":"A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for","route":"/trials/nct07728955/","status":"planned","tldr":"A phase 3 trial of anlotinib and etoposide in lung cancer, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, not yet recruiting."},{"id":"nct07242274","kind":"trial","name":"Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC","route":"/trials/nct07242274/","status":"planned","tldr":"A phase 3 trial of docetaxel in lung cancer, run by Jemincare, not yet recruiting."},{"id":"nct06672068","kind":"trial","name":"A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC","route":"/trials/nct06672068/","status":"planned","tldr":"A phase 2 trial of pemetrexed, cisplatin and carboplatin in lung cancer, run by TYK Medicines, Inc, not yet recruiting."},{"id":"nct07453394","kind":"trial","name":"QLS5132 Combination Therapy in Advanced Solid Tumors","route":"/trials/nct07453394/","status":"planned","tldr":"A phase 1/2 trial of bevacizumab, olaparib, iparomlimab and tuvonralimab, QL2107 and other drugs in lung cancer, run by Qilu Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06683703","kind":"trial","name":"Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases","route":"/trials/nct06683703/","status":"planned","tldr":"A phase 2 trial of utidelone and bevacizumab in lung cancer, run by Beijing Biostar Pharmaceuticals Co., Ltd., not yet recruiting."},{"id":"nct07633873","kind":"trial","name":"SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNST","route":"/trials/nct07633873/","status":"planned","tldr":"A phase 3 trial of tislelizumab, paclitaxel / nab-paclitaxel, cisplatin and carboplatin in lung cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., not yet recruiting."},{"id":"nct07816380","kind":"trial","name":"A Phase III Study to Evaluate the Efficacy and Safety of JYP0322 in Previously Untreated ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer","route":"/trials/nct07816380/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Guangzhou JOYO Pharma Co., Ltd, not yet recruiting."},{"id":"nct06704620","kind":"trial","name":"Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Can","route":"/trials/nct06704620/","status":"planned","tldr":"A phase 3 trial of tislelizumab, pemetrexed, carboplatin and cisplatin in lung cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting."},{"id":"nct06469879","kind":"trial","name":"A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients","route":"/trials/nct06469879/","status":"planned","tldr":"A phase 3 trial of benmelstobart and anlotinib in lung cancer, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., not yet recruiting."},{"id":"nct07343479","kind":"trial","name":"Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases","route":"/trials/nct07343479/","status":"planned","tldr":"A phase 2 trial of sacituzumab tirumotecan in lung cancer, run by Zhejiang Cancer Hospital, not yet recruiting."},{"id":"nct07162883","kind":"trial","name":"Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)","route":"/trials/nct07162883/","status":"planned","tldr":"A phase 3 trial of QL2107 and pembrolizumab in lung cancer, run by Qilu Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06961188","kind":"trial","name":"Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis","route":"/trials/nct06961188/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Changchun GeneScience Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06319313","kind":"trial","name":"Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer","route":"/trials/nct06319313/","status":"planned","tldr":"A phase 2/3 trial of JMT101, docetaxel and HB1801 in lung cancer, run by Shanghai JMT-Bio Inc., not yet recruiting."},{"id":"nct07383116","kind":"trial","name":"Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous No","route":"/trials/nct07383116/","status":"planned","tldr":"A phase 3 trial of pemetrexed, carboplatin, cisplatin and tislelizumab in lung cancer, run by Shanghai Huaota Biopharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07158840","kind":"trial","name":"AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor","route":"/trials/nct07158840/","status":"planned","tldr":"A phase 2 trial of ivonescimab in lung cancer, run by Akeso, not yet recruiting."},{"id":"nct07551635","kind":"trial","name":"SMARCA4/2 Inhibitor for POU2F3-Positive SCLC","route":"/trials/nct07551635/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Dana-Farber Cancer Institute, not yet recruiting."},{"id":"nct07146230","kind":"trial","name":"The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2","route":"/trials/nct07146230/","status":"planned","tldr":"A phase 2 trial of durvalumab, monalizumab and oleclumab in lung cancer, run by Montefiore Medical Center, not yet recruiting."},{"id":"nct07551414","kind":"trial","name":"Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI","route":"/trials/nct07551414/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting."},{"id":"nct07819591","kind":"trial","name":"Paclitaxel Polymeric Micelles Plus Ivonescimab in Recurrent or Refractory SCLC","route":"/trials/nct07819591/","status":"planned","tldr":"A phase 2 trial of ivonescimab in lung cancer, run by Shaodong Hong, not yet recruiting."},{"id":"nct07636226","kind":"trial","name":"QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer","route":"/trials/nct07636226/","status":"planned","tldr":"A phase 2/3 trial of iparomlimab and tuvonralimab and anlotinib in lung cancer, run by Sun Yat-sen University, not yet recruiting."},{"id":"nct07739186","kind":"trial","name":"A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment f","route":"/trials/nct07739186/","status":"planned","tldr":"A phase 2/3 trial of izalontamab brengitecan, tislelizumab, pemetrexed, carboplatin and other drugs in lung cancer, run by Sichuan Baili Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07101627","kind":"trial","name":"A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy","route":"/trials/nct07101627/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Shanghai Pulmonary Hospital, Shanghai, China, not yet recruiting."},{"id":"nct07829549","kind":"trial","name":"Phase III Study of RC148 Plus Chemotherapy Versus Tislelizumab Plus Chemotherapy as First-Line Treatment for Non-Squamous Non-Small Cell Lung Cancer Without Act","route":"/trials/nct07829549/","status":"planned","tldr":"A phase 3 trial of carboplatin and tislelizumab in lung cancer, run by RemeGen Co., Ltd., not yet recruiting."},{"id":"nct07819578","kind":"trial","name":"Toripalimab Plus Sacituzumab Tirumotecan as Neoadjuvant Therapy for Resectable NSCLC","route":"/trials/nct07819578/","status":"planned","tldr":"A phase 2 trial of toripalimab and sacituzumab tirumotecan in lung cancer, run by Shaodong Hong, not yet recruiting."},{"id":"nct06323148","kind":"trial","name":"Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)","route":"/trials/nct06323148/","status":"planned","tldr":"A phase 3 trial of osimertinib in lung cancer, run by Fudan University, not yet recruiting."},{"id":"nct04846634","kind":"trial","name":"Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (A","route":"/trials/nct04846634/","status":"planned","tldr":"A phase 2 trial of penpulimab, cisplatin, carboplatin, pemetrexed and other drugs in lung cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting."},{"id":"nct06780839","kind":"trial","name":"Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD","route":"/trials/nct06780839/","status":"planned","tldr":"A phase 2 trial of ensartinib in lung cancer, run by Peking University Cancer Hospital & Institute, not yet recruiting."},{"id":"nct07680790","kind":"trial","name":"Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based C","route":"/trials/nct07680790/","status":"planned","tldr":"A phase 3 trial of izalontamab brengitecan, osimertinib, pemetrexed, carboplatin and other drugs in lung cancer, run by Bristol-Myers Squibb, not yet recruiting."},{"id":"nct07802821","kind":"trial","name":"A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Sm","route":"/trials/nct07802821/","status":"planned","tldr":"A phase 3 trial of QLC5508, QL2107, tislelizumab, carboplatin and other drugs in lung cancer, run by Qilu Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07802834","kind":"trial","name":"Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC","route":"/trials/nct07802834/","status":"planned","tldr":"A phase 2 trial of zipalertinib in lung cancer, run by Stanford University, not yet recruiting."},{"id":"nct07603791","kind":"trial","name":"Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC","route":"/trials/nct07603791/","status":"planned","tldr":"A phase 2 trial of carboplatin in lung cancer, run by Shanghai Allink Biotherapeutics Co., Ltd., not yet recruiting."},{"id":"nct06028633","kind":"trial","name":"Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients","route":"/trials/nct06028633/","status":"planned","tldr":"A phase 2 trial of pembrolizumab, lenvatinib and nab-paclitaxel in lung cancer, run by Peking University First Hospital, not yet recruiting."},{"id":"nct07450183","kind":"trial","name":"Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1","route":"/trials/nct07450183/","status":"planned","tldr":"A phase 2 trial of cemiplimab in lung cancer, run by Henry Ford Health System, not yet recruiting."},{"id":"nct01394679","kind":"trial","name":"A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer","route":"/trials/nct01394679/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Cell>Point LLC, not yet recruiting."},{"id":"nct07707895","kind":"trial","name":"DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers","route":"/trials/nct07707895/","status":"planned","tldr":"A phase 1/2 trial of obrixtamig, ZL-1310 and atezolizumab in lung cancer, run by Boehringer Ingelheim, not yet recruiting."},{"id":"nct07608159","kind":"trial","name":"Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.","route":"/trials/nct07608159/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Shanghai Pulmonary Hospital, Shanghai, China, not yet recruiting."},{"id":"nct07754123","kind":"trial","name":"Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC","route":"/trials/nct07754123/","status":"planned","tldr":"A phase 3 trial of cisplatin and carboplatin in lung cancer, run by Jiangsu Hansoh Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07746388","kind":"trial","name":"Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial","route":"/trials/nct07746388/","status":"planned","tldr":"A phase 2 trial of cemiplimab in lung cancer, run by University of Maryland, Baltimore, not yet recruiting."},{"id":"nct06858410","kind":"trial","name":"Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma","route":"/trials/nct06858410/","status":"planned","tldr":"A phase 3 trial of lorlatinib in lung cancer, run by Guangdong Association of Clinical Trials, not yet recruiting."},{"id":"nct05745740","kind":"trial","name":"A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation","route":"/trials/nct05745740/","status":"planned","tldr":"A phase 1/2 trial of pyrotinib in lung cancer, run by RemeGen Co., Ltd., not yet recruiting."},{"id":"nct04465968","kind":"trial","name":"Efficacy and Safety of CRT, Durvalumab and Surgery for SST","route":"/trials/nct04465968/","status":"planned","tldr":"A phase 3 trial of cisplatin and durvalumab in lung cancer, run by National Cancer Center Hospital East, not yet recruiting."},{"id":"nct06198907","kind":"trial","name":"Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)","route":"/trials/nct06198907/","status":"planned","tldr":"A phase 2 trial of golidocitinib and sintilimab in lung cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting."},{"id":"nct07283198","kind":"trial","name":"A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung Cancer","route":"/trials/nct07283198/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, not yet recruiting."},{"id":"nct07756645","kind":"trial","name":"A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advan","route":"/trials/nct07756645/","status":"planned","tldr":"A phase 3 trial of pembrolizumab, carboplatin, paclitaxel / nab-paclitaxel and nab-paclitaxel in lung cancer, run by AbbVie, not yet recruiting."},{"id":"nct07688577","kind":"trial","name":"XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors","route":"/trials/nct07688577/","status":"planned","tldr":"A phase 1/2 trial in lung cancer, run by Xilio Development, Inc., not yet recruiting."},{"id":"nct07154368","kind":"trial","name":"JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.","route":"/trials/nct07154368/","status":"planned","tldr":"A phase 3 trial of pemetrexed in lung cancer, run by Guangzhou JOYO Pharma Co., Ltd, not yet recruiting."},{"id":"nct05393466","kind":"trial","name":"BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)","route":"/trials/nct05393466/","status":"planned","tldr":"A phase 1/2 trial in lung cancer, run by Xcovery Holdings, Inc., not yet recruiting."},{"id":"nct06961201","kind":"trial","name":"Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cache","route":"/trials/nct06961201/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Changchun GeneScience Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07821684","kind":"trial","name":"A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanc","route":"/trials/nct07821684/","status":"planned","tldr":"A phase 3 trial of telisotuzumab adizutecan, docetaxel and ramucirumab in lung cancer, run by AbbVie, not yet recruiting."},{"id":"nct06102161","kind":"trial","name":"Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)","route":"/trials/nct06102161/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Fudan University, not yet recruiting."},{"id":"nct06775483","kind":"trial","name":"Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study","route":"/trials/nct06775483/","status":"planned","tldr":"A phase 2 trial of JSKN016 and docetaxel in lung cancer, run by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, not yet recruiting."},{"id":"nct05503888","kind":"trial","name":"Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer","route":"/trials/nct05503888/","status":"planned","tldr":"A phase 1/2 trial of aumolertinib and retlirafusp alfa in lung cancer, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., not yet recruiting."},{"id":"nct07043907","kind":"trial","name":"PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC","route":"/trials/nct07043907/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Shenzhen Celconta Life Science Co., Ltd., not yet recruiting."},{"id":"nct06380348","kind":"trial","name":"JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Chara","route":"/trials/nct06380348/","status":"planned","tldr":"A phase 3 trial of cisplatin and pemetrexed in lung cancer, run by Shanghai JMT-Bio Inc., not yet recruiting."},{"id":"nct07827261","kind":"trial","name":"A Study of BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer","route":"/trials/nct07827261/","status":"planned","tldr":"A phase 2 trial of izalontamab brengitecan and glecirasib in lung cancer, run by Sichuan Baili Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06416852","kind":"trial","name":"Clinical Study of 18F-Alfatide Injection PET/CT","route":"/trials/nct06416852/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Yantai LNC Biotechnology Singapore PTE. LTD., not yet recruiting."},{"id":"nct06951399","kind":"trial","name":"Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer","route":"/trials/nct06951399/","status":"planned","tldr":"A phase 2 trial of pembrolizumab in lung cancer, run by Rabin Medical Center, not yet recruiting."},{"id":"nct05990127","kind":"trial","name":"A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer","route":"/trials/nct05990127/","status":"planned","tldr":"A phase 3 trial of cadonilimab, tislelizumab, carboplatin, pemetrexed and other drugs in lung cancer, run by Akeso, not yet recruiting."},{"id":"nct07617389","kind":"trial","name":"Selective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cance","route":"/trials/nct07617389/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Wen-zhao ZHONG, not yet recruiting."},{"id":"nct07464327","kind":"trial","name":"A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-S","route":"/trials/nct07464327/","status":"planned","tldr":"A phase 3 trial of HS-20093 and docetaxel in lung cancer, run by Hansoh BioMedical R&D Company, not yet recruiting."},{"id":"nct07294261","kind":"trial","name":"Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC","route":"/trials/nct07294261/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Sun Yat-sen University, not yet recruiting."},{"id":"nct07414927","kind":"trial","name":"A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following E","route":"/trials/nct07414927/","status":"planned","tldr":"A phase 1/2 trial in lung cancer, run by Shanghai Best-Link Bioscience, LLC, not yet recruiting."},{"id":"nct07472647","kind":"trial","name":"SYS6090 Combination Therapy in Advanced Lung Cancer","route":"/trials/nct07472647/","status":"planned","tldr":"A phase 1/2 trial of pemetrexed, paclitaxel / nab-paclitaxel, docetaxel, bevacizumab and other drugs in lung cancer, run by Shanghai JMT-Bio Inc., not yet recruiting."},{"id":"nct07106528","kind":"trial","name":"Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer","route":"/trials/nct07106528/","status":"planned","tldr":"A phase 2/3 trial of topotecan in lung cancer, run by Peking Union Medical College Hospital, not yet recruiting."},{"id":"nct06719336","kind":"trial","name":"Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)","route":"/trials/nct06719336/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Anhui Shi, MD, not yet recruiting."},{"id":"nct07197853","kind":"trial","name":"Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Granules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A Prospective,","route":"/trials/nct07197853/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Xin Ye, not yet recruiting."},{"id":"nct07831863","kind":"trial","name":"A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy","route":"/trials/nct07831863/","status":"planned","tldr":"A phase 3 trial of docetaxel in lung cancer, run by Mabwell (Shanghai) Bioscience Co., Ltd., not yet recruiting."},{"id":"nct07442565","kind":"trial","name":"SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase III","route":"/trials/nct07442565/","status":"planned","tldr":"A phase 3 trial of SYS6010 and docetaxel in lung cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., not yet recruiting."},{"id":"nct06982924","kind":"trial","name":"A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC.","route":"/trials/nct06982924/","status":"planned","tldr":"A phase 2 trial of limertinib and bevacizumab in lung cancer, run by Shanghai Chest Hospital, not yet recruiting."},{"id":"nct07806773","kind":"trial","name":"Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung Cancer","route":"/trials/nct07806773/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Tubulis GmbH, not yet recruiting."},{"id":"nct06048315","kind":"trial","name":"A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs W","route":"/trials/nct06048315/","status":"planned","tldr":"A phase 3 trial of anlotinib and penpulimab in lung cancer, run by Degan Lu, not yet recruiting."},{"id":"nct07609251","kind":"trial","name":"A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study","route":"/trials/nct07609251/","status":"planned","tldr":"A phase 2 trial of SCTB41 and docetaxel in lung cancer, run by Sinocelltech Ltd., not yet recruiting."},{"id":"nct07361484","kind":"trial","name":"Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)","route":"/trials/nct07361484/","status":"planned","tldr":"A phase 3 trial of docetaxel in lung cancer, run by BeyondSpring Pharmaceuticals Inc., not yet recruiting."},{"id":"nct06254599","kind":"trial","name":"A Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC","route":"/trials/nct06254599/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Shouyao Holdings (Beijing) Co. LTD, not yet recruiting."},{"id":"nct07672223","kind":"trial","name":"A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)","route":"/trials/nct07672223/","status":"planned","tldr":"A phase 3 trial of SYS6010, tislelizumab, toripalimab, durvalumab and other drugs in lung cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., not yet recruiting."},{"id":"nct06885840","kind":"trial","name":"Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.","route":"/trials/nct06885840/","status":"planned","tldr":"A phase 2 trial of MCLA-129 in lung cancer, run by Betta Pharmaceuticals Co., Ltd., not yet recruiting."},{"id":"nct07833202","kind":"trial","name":"A Phase 3 Study of Sosimerasib in Combination With IN10018 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutatio","route":"/trials/nct07833202/","status":"planned","tldr":"A phase 3 trial of IN10018, tislelizumab, carboplatin and pemetrexed in lung cancer, run by Shanghai Jeyou Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct06525350","kind":"trial","name":"A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed","route":"/trials/nct06525350/","status":"planned","tldr":"A phase 2 trial of docetaxel in lung cancer, run by CSPC ZhongQi Pharmaceutical Technology Co., Ltd., not yet recruiting."},{"id":"nct07538271","kind":"trial","name":"A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer","route":"/trials/nct07538271/","status":"planned","tldr":"A phase 2 trial of benmelstobart, anlotinib and etoposide in lung cancer, run by Yayi He, not yet recruiting."},{"id":"nct07376382","kind":"trial","name":"A Phase III Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC","route":"/trials/nct07376382/","status":"planned","tldr":"A phase 3 trial of SYS6010 and osimertinib in lung cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., not yet recruiting."},{"id":"nct07229339","kind":"trial","name":"Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer","route":"/trials/nct07229339/","status":"planned","tldr":"A phase 2 trial of carboplatin, pemetrexed and zipalertinib in lung cancer, run by Jonsson Comprehensive Cancer Center, not yet recruiting."},{"id":"nct04772287","kind":"trial","name":"Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)","route":"/trials/nct04772287/","status":"planned","tldr":"A phase 3 trial of toripalimab in lung cancer, run by Shanghai Pulmonary Hospital, Shanghai, China, not yet recruiting."},{"id":"nct06335355","kind":"trial","name":"A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients","route":"/trials/nct06335355/","status":"planned","tldr":"A phase 2/3 trial of adebrelimab, SHR-8068, pemetrexed, carboplatin and other drugs in lung cancer, run by Shanghai Shengdi Pharmaceutical Co., Ltd, not yet recruiting."},{"id":"nct07160686","kind":"trial","name":"Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment","route":"/trials/nct07160686/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by University of Birmingham, not yet recruiting."},{"id":"nct07554859","kind":"trial","name":"GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung Cancer","route":"/trials/nct07554859/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by Genfleet Therapeutics (Shanghai) Inc., not yet recruiting."},{"id":"nct07715396","kind":"trial","name":"Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden","route":"/trials/nct07715396/","status":"planned","tldr":"A phase 3 trial of tislelizumab and pembrolizumab in lung cancer, run by AIO-Studien-gGmbH, not yet recruiting."},{"id":"nct07824882","kind":"trial","name":"A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamo","route":"/trials/nct07824882/","status":"planned","tldr":"A phase 2 trial of adebrelimab in lung cancer, run by Hansoh BioMedical R&D Company, not yet recruiting."},{"id":"nct07822542","kind":"trial","name":"A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Pat","route":"/trials/nct07822542/","status":"planned","tldr":"A phase 3 trial of adebrelimab, cisplatin, carboplatin, pemetrexed and other drugs in lung cancer, run by Jiangsu Hansoh Pharmaceutical Co., Ltd., not yet recruiting."},{"id":"nct07150416","kind":"trial","name":"Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study","route":"/trials/nct07150416/","status":"planned","tldr":"A phase 2 trial in lung cancer, run by The First Affiliated Hospital of Guangzhou Medical University, not yet recruiting."},{"id":"nct06828757","kind":"trial","name":"Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer","route":"/trials/nct06828757/","status":"planned","tldr":"A phase 3 trial in lung cancer, run by Hunan Province Tumor Hospital, not yet recruiting."},{"id":"nct07662811","kind":"trial","name":"SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer","route":"/trials/nct07662811/","status":"planned","tldr":"A phase 2/3 trial of carboplatin, nab-paclitaxel and tislelizumab in lung cancer, run by Shanghai Chest Hospital, not yet recruiting."},{"id":"nct07323641","kind":"trial","name":"Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer","route":"/trials/nct07323641/","status":"recruiting","tldr":"A phase 2 trial of osimertinib and telisotuzumab vedotin in lung cancer, run by Jonsson Comprehensive Cancer Center, now recruiting."},{"id":"nct05085028","kind":"trial","name":"A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung","route":"/trials/nct05085028/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Imperial College London, now recruiting."},{"id":"nct07057791","kind":"trial","name":"Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer","route":"/trials/nct07057791/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by PrECOG, LLC., now recruiting."},{"id":"nct06315010","kind":"trial","name":"Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain Metastasis","route":"/trials/nct06315010/","status":"recruiting","tldr":"A phase 2 trial of repotrectinib in lung cancer, run by MedSIR, now recruiting."},{"id":"nct05825443","kind":"trial","name":"Adjuvant Chemotherapy Combined With Camrelizumab for IIA -IIIA NSCLC Patients","route":"/trials/nct05825443/","status":"recruiting","tldr":"A phase 2 trial of camrelizumab in lung cancer, run by Nanfang Hospital, Southern Medical University, now recruiting."},{"id":"nct07153055","kind":"trial","name":"Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer","route":"/trials/nct07153055/","status":"recruiting","tldr":"A phase 1/2 trial of lurbinectedin and osimertinib in lung cancer, run by Misty Shields, now recruiting."},{"id":"nct07034326","kind":"trial","name":"Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer","route":"/trials/nct07034326/","status":"recruiting","tldr":"A phase 2/3 trial in lung cancer, run by Kong Fanming, now recruiting."},{"id":"nct05607108","kind":"trial","name":"A Study of ZEN003694 in People With Squamous Cell Lung Cancer","route":"/trials/nct05607108/","status":"recruiting","tldr":"A phase 2 trial of ZEN-3694 in lung cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting."},{"id":"nct07149363","kind":"trial","name":"Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer","route":"/trials/nct07149363/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Alliance Foundation Trials, LLC., now recruiting."},{"id":"nct04691817","kind":"trial","name":"Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based T","route":"/trials/nct04691817/","status":"recruiting","tldr":"A phase 1/2 trial of atezolizumab and tocilizumab in lung cancer, run by Abramson Cancer Center at Penn Medicine, now recruiting."},{"id":"nct07559929","kind":"trial","name":"A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.","route":"/trials/nct07559929/","status":"recruiting","tldr":"A phase 1/2 trial of toripalimab, carboplatin and cisplatin in lung cancer, run by Hangzhou DAC Biotechnology Co., Ltd., now recruiting."},{"id":"nct06478108","kind":"trial","name":"Interventional Software for Multi-immunotherapy of Solid Tumors","route":"/trials/nct06478108/","status":"recruiting","tldr":"A phase 2/3 trial in lung cancer, run by Second Affiliated Hospital of Guangzhou Medical University, now recruiting."},{"id":"nct06814496","kind":"trial","name":"Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors","route":"/trials/nct06814496/","status":"recruiting","tldr":"A phase 1/2 trial of tarlatamab in lung cancer, run by University of Arizona, now recruiting."},{"id":"nct05718323","kind":"trial","name":"Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC","route":"/trials/nct05718323/","status":"recruiting","tldr":"A phase 2 trial of niraparib in lung cancer, run by ETOP IBCSG Partners Foundation, now recruiting."},{"id":"nct06177925","kind":"trial","name":"A Phase II Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC","route":"/trials/nct06177925/","status":"recruiting","tldr":"A phase 2 trial of adebrelimab, carboplatin, cisplatin and etoposide in lung cancer, run by Nanfang Hospital, Southern Medical University, now recruiting."},{"id":"nct05903092","kind":"trial","name":"MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer","route":"/trials/nct05903092/","status":"recruiting","tldr":"A phase 2 trial of durvalumab, monalizumab and etoposide in lung cancer, run by Hirva Mamdani, now recruiting."},{"id":"nct07149649","kind":"trial","name":"Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)","route":"/trials/nct07149649/","status":"recruiting","tldr":"A phase 2/3 trial in lung cancer, run by Swiss Cancer Institute, now recruiting."},{"id":"nct07132190","kind":"trial","name":"Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction","route":"/trials/nct07132190/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Ayal A. Aizer, MD, now recruiting."},{"id":"nct07219576","kind":"trial","name":"Retifanlimab and Ruxolitinib In Solid Malignancies","route":"/trials/nct07219576/","status":"recruiting","tldr":"A phase 1/2 trial of ruxolitinib and retifanlimab in lung cancer, run by University of California, San Diego, now recruiting."},{"id":"nct01639508","kind":"trial","name":"Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or A","route":"/trials/nct01639508/","status":"recruiting","tldr":"A phase 2 trial of cabozantinib in lung cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting."},{"id":"nct04585490","kind":"trial","name":"Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC","route":"/trials/nct04585490/","status":"recruiting","tldr":"A phase 3 trial of durvalumab, carboplatin, pemetrexed, paclitaxel / nab-paclitaxel and other drugs in lung cancer, run by Maximilian Diehn, now recruiting."},{"id":"nct06284317","kind":"trial","name":"A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Canc","route":"/trials/nct06284317/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by ETOP IBCSG Partners Foundation, now recruiting."},{"id":"nct07251582","kind":"trial","name":"Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer","route":"/trials/nct07251582/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Hunan Province Tumor Hospital, now recruiting."},{"id":"nct07535463","kind":"trial","name":"A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer","route":"/trials/nct07535463/","status":"recruiting","tldr":"A phase 1/2 trial of ivonescimab in lung cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting."},{"id":"nct06616584","kind":"trial","name":"Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemoth","route":"/trials/nct06616584/","status":"recruiting","tldr":"A phase 2/3 trial of cemiplimab, dexamethasone, docetaxel and ramucirumab in lung cancer, run by SWOG Cancer Research Network, now recruiting."},{"id":"nct05852990","kind":"trial","name":"Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC","route":"/trials/nct05852990/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Instituto Nacional de Cancerologia de Mexico, now recruiting."},{"id":"nct07213375","kind":"trial","name":"High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy","route":"/trials/nct07213375/","status":"recruiting","tldr":"A phase 2/3 trial of dexamethasone in lung cancer, run by Rigshospitalet, Denmark, now recruiting."},{"id":"nct06674343","kind":"trial","name":"Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations","route":"/trials/nct06674343/","status":"recruiting","tldr":"A phase 3 trial of furmonertinib in lung cancer, run by Peking Union Medical College Hospital, now recruiting."},{"id":"nct05469022","kind":"trial","name":"Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy","route":"/trials/nct05469022/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Konkuk University Medical Center, now recruiting."},{"id":"nct05624996","kind":"trial","name":"Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer","route":"/trials/nct05624996/","status":"recruiting","tldr":"A phase 3 trial of carboplatin, cisplatin, durvalumab, etoposide and other drugs in lung cancer, run by NRG Oncology, now recruiting."},{"id":"nct06110572","kind":"trial","name":"Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation","route":"/trials/nct06110572/","status":"recruiting","tldr":"A phase 1/2 trial of carboplatin, atezolizumab and etoposide in lung cancer, run by Vanderbilt-Ingram Cancer Center, now recruiting."},{"id":"nct06698965","kind":"trial","name":"Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and C","route":"/trials/nct06698965/","status":"recruiting","tldr":"A phase 2 trial of carboplatin and trilaciclib in lung cancer, run by Shanghai Chest Hospital, now recruiting."},{"id":"nct06663098","kind":"trial","name":"Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).","route":"/trials/nct06663098/","status":"recruiting","tldr":"A phase 2 trial of atezolizumab, carboplatin and etoposide in lung cancer, run by Gruppo Oncologico Italiano di Ricerca Clinica, now recruiting."},{"id":"nct05987644","kind":"trial","name":"Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements","route":"/trials/nct05987644/","status":"recruiting","tldr":"A phase 1/2 trial of alectinib in lung cancer, run by Joshua Palmer, now recruiting."},{"id":"nct05623319","kind":"trial","name":"Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)","route":"/trials/nct05623319/","status":"recruiting","tldr":"A phase 2 trial of pembrolizumab and olaparib in lung cancer, run by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS, now recruiting."},{"id":"nct05450965","kind":"trial","name":"Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer","route":"/trials/nct05450965/","status":"recruiting","tldr":"A phase 2 trial of onvansertib in lung cancer, run by University of Maryland, Baltimore, now recruiting."},{"id":"nct06931717","kind":"trial","name":"A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Re","route":"/trials/nct06931717/","status":"recruiting","tldr":"A phase 3 trial of cemiplimab in lung cancer, run by ETOP IBCSG Partners Foundation, now recruiting."},{"id":"nct05918302","kind":"trial","name":"Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.","route":"/trials/nct05918302/","status":"recruiting","tldr":"A phase 3 trial of 177Lu-edotreotide and everolimus in lung cancer, run by Grupo Espanol de Tumores Neuroendocrinos, now recruiting."},{"id":"nct06810375","kind":"trial","name":"Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery","route":"/trials/nct06810375/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by George Washington University, now recruiting."},{"id":"nct05692999","kind":"trial","name":"Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study","route":"/trials/nct05692999/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting."},{"id":"nct07718243","kind":"trial","name":"Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC","route":"/trials/nct07718243/","status":"recruiting","tldr":"A phase 1/2 trial in lung cancer, run by Institute of Cancer Research, United Kingdom, now recruiting."},{"id":"nct06498635","kind":"trial","name":"Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial","route":"/trials/nct06498635/","status":"recruiting","tldr":"A phase 3 trial of durvalumab in lung cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct05502913","kind":"trial","name":"Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer","route":"/trials/nct05502913/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Soroka University Medical Center, now recruiting."},{"id":"nct05950139","kind":"trial","name":"Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC","route":"/trials/nct05950139/","status":"recruiting","tldr":"A phase 1/2 trial in lung cancer, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, now recruiting."},{"id":"nct04335292","kind":"trial","name":"Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge","route":"/trials/nct04335292/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Mark Vincent, now recruiting."},{"id":"nct02468024","kind":"trial","name":"JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer","route":"/trials/nct02468024/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by University of Texas Southwestern Medical Center, now recruiting."},{"id":"nct05445791","kind":"trial","name":"Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations","route":"/trials/nct05445791/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Instituto Nacional de Cancerologia de Mexico, now recruiting."},{"id":"nct06686771","kind":"trial","name":"Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer","route":"/trials/nct06686771/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Canadian Cancer Trials Group, now recruiting."},{"id":"nct06623656","kind":"trial","name":"Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC","route":"/trials/nct06623656/","status":"recruiting","tldr":"A phase 2 trial of cemiplimab in lung cancer, run by Weill Medical College of Cornell University, now recruiting."},{"id":"nct06987734","kind":"trial","name":"Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients","route":"/trials/nct06987734/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Shanghai Pulmonary Hospital, Shanghai, China, now recruiting."},{"id":"nct07339059","kind":"trial","name":"Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer","route":"/trials/nct07339059/","status":"recruiting","tldr":"A phase 2 trial of sacituzumab govitecan, atezolizumab and durvalumab in lung cancer, run by Bindu R Potugari, now recruiting."},{"id":"nct06864624","kind":"trial","name":"Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC","route":"/trials/nct06864624/","status":"recruiting","tldr":"A phase 2 trial of sunvozertinib in lung cancer, run by Tang-Du Hospital, now recruiting."},{"id":"nct04499053","kind":"trial","name":"Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer","route":"/trials/nct04499053/","status":"recruiting","tldr":"A phase 2 trial of durvalumab and tremelimumab in lung cancer, run by Georgetown University, now recruiting."},{"id":"nct05623267","kind":"trial","name":"Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT","route":"/trials/nct05623267/","status":"recruiting","tldr":"A phase 2/3 trial of sugemalimab in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct06457906","kind":"trial","name":"SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC","route":"/trials/nct06457906/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting."},{"id":"nct07355205","kind":"trial","name":"First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer","route":"/trials/nct07355205/","status":"recruiting","tldr":"A phase 1/2 trial of ipilimumab, nivolumab and nogapendekin alfa inbakicept in lung cancer, run by Washington University School of Medicine, now recruiting."},{"id":"nct06230445","kind":"trial","name":"Effects of Digital Therapeutic in Whole Process Management of Lung Cancer","route":"/trials/nct06230445/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct05522660","kind":"trial","name":"Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer","route":"/trials/nct05522660/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by ETOP IBCSG Partners Foundation, now recruiting."},{"id":"nct04339218","kind":"trial","name":"Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma","route":"/trials/nct04339218/","status":"recruiting","tldr":"A phase 3 trial of pembrolizumab, pemetrexed and carboplatin in lung cancer, run by Institut Bergonié, now recruiting."},{"id":"nct06908993","kind":"trial","name":"Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated","route":"/trials/nct06908993/","status":"recruiting","tldr":"A phase 3 trial of tepotinib, pemetrexed, vinorelbine, docetaxel and other drugs in lung cancer, run by Intergroupe Francophone de Cancerologie Thoracique, now recruiting."},{"id":"nct04317534","kind":"trial","name":"Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm","route":"/trials/nct04317534/","status":"recruiting","tldr":"A phase 2 trial of pembrolizumab in lung cancer, run by Greg Durm, MD, now recruiting."},{"id":"nct07001618","kind":"trial","name":"Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiot","route":"/trials/nct07001618/","status":"recruiting","tldr":"A phase 2 trial of cemiplimab, cisplatin, pemetrexed, bevacizumab and other drugs in lung cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting."},{"id":"nct07423585","kind":"trial","name":"Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer","route":"/trials/nct07423585/","status":"recruiting","tldr":"A phase 2 trial of tarlatamab in lung cancer, run by Asrar Alahmadi, now recruiting."},{"id":"nct05055908","kind":"trial","name":"Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors","route":"/trials/nct05055908/","status":"recruiting","tldr":"A phase 3 trial of pemetrexed and pembrolizumab in lung cancer, run by Hunan Province Tumor Hospital, now recruiting."},{"id":"nct06043973","kind":"trial","name":"Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance","route":"/trials/nct06043973/","status":"recruiting","tldr":"A phase 3 trial of aumolertinib in lung cancer, run by Qianfoshan Hospital, now recruiting."},{"id":"nct05632809","kind":"trial","name":"REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)","route":"/trials/nct05632809/","status":"recruiting","tldr":"A phase 2 trial of durvalumab in lung cancer, run by M.D. Anderson Cancer Center, now recruiting."},{"id":"nct07481786","kind":"trial","name":"Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases","route":"/trials/nct07481786/","status":"recruiting","tldr":"A phase 3 trial of bevacizumab in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct06840782","kind":"trial","name":"First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.","route":"/trials/nct06840782/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting."},{"id":"nct07428044","kind":"trial","name":"A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer","route":"/trials/nct07428044/","status":"recruiting","tldr":"A phase 2 trial of trastuzumab deruxtecan in lung cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting."},{"id":"nct07443397","kind":"trial","name":"Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.","route":"/trials/nct07443397/","status":"recruiting","tldr":"A phase 3 trial of anlotinib in lung cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting."},{"id":"nct07016126","kind":"trial","name":"D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC","route":"/trials/nct07016126/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Guangdong Provincial People's Hospital, now recruiting."},{"id":"nct04875585","kind":"trial","name":"Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC","route":"/trials/nct04875585/","status":"recruiting","tldr":"A phase 2 trial of pembrolizumab and lenvatinib in lung cancer, run by Medical University Innsbruck, now recruiting."},{"id":"nct06448572","kind":"trial","name":"EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.","route":"/trials/nct06448572/","status":"recruiting","tldr":"A phase 1/2 trial in lung cancer, run by University Hospital, Lille, now recruiting."},{"id":"nct06634966","kind":"trial","name":"Segmentectomy for Solid-dominant Lung Cancer","route":"/trials/nct06634966/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting."},{"id":"nct04871412","kind":"trial","name":"The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III","route":"/trials/nct04871412/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Ottawa Hospital Research Institute, now recruiting."},{"id":"nct06290869","kind":"trial","name":"Tobacco Education and Lung Health Study (TEAL)","route":"/trials/nct06290869/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Georgetown University, now recruiting."},{"id":"nct06500481","kind":"trial","name":"Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial","route":"/trials/nct06500481/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by NRG Oncology, now recruiting."},{"id":"nct05570825","kind":"trial","name":"SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer","route":"/trials/nct05570825/","status":"recruiting","tldr":"A phase 2 trial of pembrolizumab in lung cancer, run by University of Washington, now recruiting."},{"id":"nct05236946","kind":"trial","name":"Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT","route":"/trials/nct05236946/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Tata Memorial Hospital, now recruiting."},{"id":"nct06865339","kind":"trial","name":"Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer","route":"/trials/nct06865339/","status":"recruiting","tldr":"A phase 2 trial of cemiplimab and fianlimab in lung cancer, run by Montefiore Medical Center, now recruiting."},{"id":"nct05800223","kind":"trial","name":"Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer","route":"/trials/nct05800223/","status":"recruiting","tldr":"A phase 3 trial of aumolertinib in lung cancer, run by Shanghai Cancer Hospital, China, now recruiting."},{"id":"nct05501665","kind":"trial","name":"Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer","route":"/trials/nct05501665/","status":"recruiting","tldr":"A phase 1/2 trial of carboplatin, fludeoxyglucose F-18 (FDG), nab-paclitaxel, pembrolizumab and other drugs in lung cancer, run by Vanderbilt-Ingram Cancer Center, now recruiting."},{"id":"nct06523673","kind":"trial","name":"Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer","route":"/trials/nct06523673/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Second Affiliated Hospital, Zhejiang University, School of Medicine, now recruiting."},{"id":"nct06031181","kind":"trial","name":"Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)","route":"/trials/nct06031181/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting."},{"id":"nct06248606","kind":"trial","name":"Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases","route":"/trials/nct06248606/","status":"recruiting","tldr":"A phase 2 trial of adagrasib in lung cancer, run by Ryan Gentzler, MD, now recruiting."},{"id":"nct06822543","kind":"trial","name":"A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cance","route":"/trials/nct06822543/","status":"recruiting","tldr":"A phase 2 trial of pembrolizumab, datopotamab deruxtecan and carboplatin in lung cancer, run by Latin American Cooperative Oncology Group, now recruiting."},{"id":"nct07133425","kind":"trial","name":"A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer","route":"/trials/nct07133425/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by M.D. Anderson Cancer Center, now recruiting."},{"id":"nct06475209","kind":"trial","name":"Adebrelimab + Apatinib in SCLC Maintenance Therapy","route":"/trials/nct06475209/","status":"recruiting","tldr":"A phase 2 trial of adebrelimab and rivoceranib (apatinib) in lung cancer, run by Tang-Du Hospital, now recruiting."},{"id":"nct04267848","kind":"trial","name":"Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Ch","route":"/trials/nct04267848/","status":"recruiting","tldr":"A phase 3 trial of carboplatin, cisplatin, gemcitabine, paclitaxel / nab-paclitaxel and other drugs in lung cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct05286957","kind":"trial","name":"MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC","route":"/trials/nct05286957/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by The First Affiliated Hospital of Zhengzhou University, now recruiting."},{"id":"nct07602855","kind":"trial","name":"A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)","route":"/trials/nct07602855/","status":"recruiting","tldr":"A phase 1/2 trial of ivonescimab in lung cancer, run by GlaxoSmithKline, now recruiting."},{"id":"nct05429463","kind":"trial","name":"Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE II）","route":"/trials/nct05429463/","status":"recruiting","tldr":"A phase 3 trial of sintilimab, carboplatin and nab-paclitaxel in lung cancer, run by Second Affiliated Hospital, Zhejiang University, School of Medicine, now recruiting."},{"id":"nct07224152","kind":"trial","name":"NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer","route":"/trials/nct07224152/","status":"recruiting","tldr":"A phase 1/2 trial of JNJ-90301900 in lung cancer, run by M.D. Anderson Cancer Center, now recruiting."},{"id":"nct07485452","kind":"trial","name":"Boosting Osimertinib Blood Brain Barrier Penetration","route":"/trials/nct07485452/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Maastricht University Medical Center, now recruiting."},{"id":"nct05255302","kind":"trial","name":"De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction","route":"/trials/nct05255302/","status":"recruiting","tldr":"A phase 2/3 trial of pemetrexed in lung cancer, run by Intergroupe Francophone de Cancerologie Thoracique, now recruiting."},{"id":"nct04410796","kind":"trial","name":"Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers","route":"/trials/nct04410796/","status":"recruiting","tldr":"A phase 2 trial of osimertinib, carboplatin and pemetrexed in lung cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting."},{"id":"nct06607796","kind":"trial","name":"Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy","route":"/trials/nct06607796/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Zhou Chengzhi, now recruiting."},{"id":"nct06096844","kind":"trial","name":"Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial","route":"/trials/nct06096844/","status":"recruiting","tldr":"A phase 3 trial of carboplatin, nab-paclitaxel, paclitaxel / nab-paclitaxel, pembrolizumab and other drugs in lung cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct05588388","kind":"trial","name":"Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases","route":"/trials/nct05588388/","status":"recruiting","tldr":"A phase 2 trial of bevacizumab in lung cancer, run by Kamya Sankar, now recruiting."},{"id":"nct07131319","kind":"trial","name":"SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC","route":"/trials/nct07131319/","status":"recruiting","tldr":"A phase 2/3 trial in lung cancer, run by Second Affiliated Hospital of Nanchang University, now recruiting."},{"id":"nct06102057","kind":"trial","name":"PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC","route":"/trials/nct06102057/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by TheraOp, now recruiting."},{"id":"nct06610734","kind":"trial","name":"Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Ext","route":"/trials/nct06610734/","status":"recruiting","tldr":"A phase 2 trial of adebrelimab in lung cancer, run by Sichuan University, now recruiting."},{"id":"nct04322617","kind":"trial","name":"Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer","route":"/trials/nct04322617/","status":"recruiting","tldr":"A phase 2/3 trial of anlotinib in lung cancer, run by Hunan Province Tumor Hospital, now recruiting."},{"id":"nct04966663","kind":"trial","name":"Using ctDNA to Determine Therapies for Lung Cancer","route":"/trials/nct04966663/","status":"recruiting","tldr":"A phase 2 trial of nivolumab, pemetrexed, gemcitabine, cisplatin and other drugs in lung cancer, run by University Health Network, Toronto, now recruiting."},{"id":"nct07052669","kind":"trial","name":"Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC","route":"/trials/nct07052669/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct07388524","kind":"trial","name":"Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial","route":"/trials/nct07388524/","status":"recruiting","tldr":"A phase 3 trial of atezolizumab in lung cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct06031246","kind":"trial","name":"Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)","route":"/trials/nct06031246/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting."},{"id":"nct06338683","kind":"trial","name":"Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer","route":"/trials/nct06338683/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Qinghai Red Cross Hospital, now recruiting."},{"id":"nct07050043","kind":"trial","name":"Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC","route":"/trials/nct07050043/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Dr Arvindran A/L Alaga, now recruiting."},{"id":"nct06222489","kind":"trial","name":"Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT","route":"/trials/nct06222489/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by The Netherlands Cancer Institute, now recruiting."},{"id":"nct07535437","kind":"trial","name":"A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer","route":"/trials/nct07535437/","status":"recruiting","tldr":"A phase 1/2 trial of ivonescimab, datopotamab deruxtecan and osimertinib in lung cancer, run by Memorial Sloan Kettering Cancer Center, now recruiting."},{"id":"nct07809256","kind":"trial","name":"A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in Patients With Metastati","route":"/trials/nct07809256/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by EuroCityClinic LLC, now recruiting."},{"id":"nct07058519","kind":"trial","name":"A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC","route":"/trials/nct07058519/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by Shanghai Chest Hospital, now recruiting."},{"id":"nct05334277","kind":"trial","name":"Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA","route":"/trials/nct05334277/","status":"recruiting","tldr":"A phase 2 trial of furmonertinib, pemetrexed, carboplatin and bevacizumab in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct06840704","kind":"trial","name":"Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer","route":"/trials/nct06840704/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Hunan Cancer Hospital, now recruiting."},{"id":"nct06951646","kind":"trial","name":"ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)","route":"/trials/nct06951646/","status":"recruiting","tldr":"A phase 2 trial of ivonescimab and docetaxel in lung cancer, run by Second Xiangya Hospital of Central South University, now recruiting."},{"id":"nct04980716","kind":"trial","name":"Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients","route":"/trials/nct04980716/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct07008716","kind":"trial","name":"Omitting CTV for Primary Tumor in LS-SCLC","route":"/trials/nct07008716/","status":"recruiting","tldr":"A phase 3 trial of etoposide, carboplatin and cisplatin in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct05278052","kind":"trial","name":"Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC","route":"/trials/nct05278052/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Tata Memorial Hospital, now recruiting."},{"id":"nct07016230","kind":"trial","name":"Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocri","route":"/trials/nct07016230/","status":"recruiting","tldr":"A phase 2 trial of tarlatamab in lung cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting."},{"id":"nct06851663","kind":"trial","name":"Trop2-targeted immunoPET Imaging of Solid Tumors","route":"/trials/nct06851663/","status":"recruiting","tldr":"A phase 2/3 trial in lung cancer, run by RenJi Hospital, now recruiting."},{"id":"nct06449313","kind":"trial","name":"Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features","route":"/trials/nct06449313/","status":"recruiting","tldr":"A phase 2 trial of cemiplimab in lung cancer, run by Georgetown University, now recruiting."},{"id":"nct07554846","kind":"trial","name":"Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC","route":"/trials/nct07554846/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting."},{"id":"nct07198841","kind":"trial","name":"IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation","route":"/trials/nct07198841/","status":"recruiting","tldr":"A phase 2 trial of fulzerasib and cetuximab in lung cancer, run by Guangdong Association of Clinical Trials, now recruiting."},{"id":"nct06545747","kind":"trial","name":"Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI","route":"/trials/nct06545747/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct06127654","kind":"trial","name":"Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy","route":"/trials/nct06127654/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by University of Sydney, now recruiting."},{"id":"nct06437977","kind":"trial","name":"Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)","route":"/trials/nct06437977/","status":"recruiting","tldr":"A phase 3 trial of toripalimab in lung cancer, run by Shanghai Chest Hospital, now recruiting."},{"id":"nct07738172","kind":"trial","name":"Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung Cancer","route":"/trials/nct07738172/","status":"recruiting","tldr":"A phase 3 trial of osimertinib in lung cancer, run by National Taiwan University Hospital, now recruiting."},{"id":"nct06734702","kind":"trial","name":"Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Ca","route":"/trials/nct06734702/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting."},{"id":"nct07110103","kind":"trial","name":"Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC","route":"/trials/nct07110103/","status":"recruiting","tldr":"A phase 2 trial of golidocitinib in lung cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting."},{"id":"nct07155200","kind":"trial","name":"Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)","route":"/trials/nct07155200/","status":"recruiting","tldr":"A phase 1/2 trial of fOLFIRI (5-FU, leucovorin, irinotecan) in lung cancer, run by Washington University School of Medicine, now recruiting."},{"id":"nct05578326","kind":"trial","name":"Study of Trilaciclib and Lurbinectidin","route":"/trials/nct05578326/","status":"recruiting","tldr":"A phase 2 trial of trilaciclib and lurbinectedin in lung cancer, run by UNC Lineberger Comprehensive Cancer Center, now recruiting."},{"id":"nct07412262","kind":"trial","name":"A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and Hig","route":"/trials/nct07412262/","status":"recruiting","tldr":"A phase 2 trial of ivonescimab in lung cancer, run by Guangdong Association of Clinical Trials, now recruiting."},{"id":"nct06401824","kind":"trial","name":"Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases","route":"/trials/nct06401824/","status":"recruiting","tldr":"A phase 2 trial of bevacizumab in lung cancer, run by Maastricht University Medical Center, now recruiting."},{"id":"nct06745882","kind":"trial","name":"Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC","route":"/trials/nct06745882/","status":"recruiting","tldr":"A phase 2 trial of cisplatin, carboplatin, pemetrexed, pembrolizumab and other drugs in lung cancer, run by H. Lee Moffitt Cancer Center and Research Institute, now recruiting."},{"id":"nct07322341","kind":"trial","name":"SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer","route":"/trials/nct07322341/","status":"recruiting","tldr":"A phase 2 trial of atezolizumab in lung cancer, run by University of Washington, now recruiting."},{"id":"nct06784791","kind":"trial","name":"Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mut","route":"/trials/nct06784791/","status":"recruiting","tldr":"A phase 2 trial of carboplatin and pemetrexed in lung cancer, run by University Hospital, Essen, now recruiting."},{"id":"nct06634056","kind":"trial","name":"Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation","route":"/trials/nct06634056/","status":"recruiting","tldr":"A phase 2 trial in lung cancer, run by University Health Network, Toronto, now recruiting."},{"id":"nct04181060","kind":"trial","name":"Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer","route":"/trials/nct04181060/","status":"recruiting","tldr":"A phase 3 trial of bevacizumab and osimertinib in lung cancer, run by National Cancer Institute (NCI), now recruiting."},{"id":"nct07405190","kind":"trial","name":"Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC","route":"/trials/nct07405190/","status":"recruiting","tldr":"A phase 2 trial of ivonescimab, carboplatin and pemetrexed in lung cancer, run by Massachusetts General Hospital, now recruiting."},{"id":"nct04829708","kind":"trial","name":"Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission Aft","route":"/trials/nct04829708/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Shandong Cancer Hospital and Institute, now recruiting."},{"id":"nct04933903","kind":"trial","name":"BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab","route":"/trials/nct04933903/","status":"recruiting","tldr":"A phase 2 trial of ipilimumab and nivolumab in lung cancer, run by Brown University, now recruiting."},{"id":"nct07203053","kind":"trial","name":"A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2","route":"/trials/nct07203053/","status":"recruiting","tldr":"A phase 2 trial of tarlatamab in lung cancer, run by ETOP IBCSG Partners Foundation, now recruiting."},{"id":"nct06598527","kind":"trial","name":"Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant The","route":"/trials/nct06598527/","status":"recruiting","tldr":"A phase 3 trial of tislelizumab in lung cancer, run by Yang Hong, now recruiting."},{"id":"nct07655622","kind":"trial","name":"Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression","route":"/trials/nct07655622/","status":"recruiting","tldr":"A phase 1/2 trial of vebreltinib in lung cancer, run by Second Affiliated Hospital of Nanchang University, now recruiting."},{"id":"nct07492342","kind":"trial","name":"Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC","route":"/trials/nct07492342/","status":"recruiting","tldr":"A phase 2 trial of fulzerasib in lung cancer, run by Jianxing He, now recruiting."},{"id":"nct06431633","kind":"trial","name":"Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.","route":"/trials/nct06431633/","status":"recruiting","tldr":"A phase 3 trial of zimberelimab, sacituzumab govitecan, cisplatin and carboplatin in lung cancer, run by Fundación GECP, now recruiting."},{"id":"nct02448992","kind":"trial","name":"Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer","route":"/trials/nct02448992/","status":"recruiting","tldr":"A phase 2/3 trial in lung cancer, run by Chang Gung Memorial Hospital, now recruiting."},{"id":"nct07815223","kind":"trial","name":"A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradiotherapy in LS-SCLC","route":"/trials/nct07815223/","status":"recruiting","tldr":"A phase 2 trial of tislelizumab and anlotinib in lung cancer, run by Yantai Yuhuangding Hospital, now recruiting."},{"id":"nct04273061","kind":"trial","name":"Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity","route":"/trials/nct04273061/","status":"recruiting","tldr":"A phase 2 trial of atezolizumab in lung cancer, run by British Columbia Cancer Agency, now recruiting."},{"id":"nct06121505","kind":"trial","name":"Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer","route":"/trials/nct06121505/","status":"recruiting","tldr":"A phase 2 trial of sintilimab in lung cancer, run by Sichuan University, now recruiting."},{"id":"nct04919382","kind":"trial","name":"Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer","route":"/trials/nct04919382/","status":"recruiting","tldr":"A phase 2 trial of atezolizumab and temozolomide in lung cancer, run by Dwight Owen, now recruiting."},{"id":"nct06141070","kind":"trial","name":"Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease","route":"/trials/nct06141070/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Vastra Gotaland Region, now recruiting."},{"id":"nct07015892","kind":"trial","name":"Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial","route":"/trials/nct07015892/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Instituto de Investigación Biomédica de Salamanca, now recruiting."},{"id":"nct05717803","kind":"trial","name":"Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)","route":"/trials/nct05717803/","status":"recruiting","tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting."},{"id":"nct06672133","kind":"trial","name":"Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC","route":"/trials/nct06672133/","status":"planned","tldr":"A phase 3 trial of adebrelimab in lung cancer, run by Jinming Yu, not yet recruiting."},{"id":"nct06441344","kind":"trial","name":"Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell","route":"/trials/nct06441344/","status":"planned","tldr":"A phase 3 trial of toripalimab and anlotinib in lung cancer, run by Taizhou Hospital, not yet recruiting."}]}